statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Genomenon Partners with Pharming to Advance APDS Diagnosis Genomenon Partners with Pharming to Advance APDS Diagnosis PR Newswire ANN ARBOR, Mich., May 2, 2024 Genomenon Making Variant Data on the...

Genomenon Partners with Pharming to Advance APDS Diagnosis

This multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Leiden, the Netherlands, April 8, 2024: Pharming...

Pharming announces completion of enrollment in pediatric clinical trial of leniolisib

Pharming Group Nv (PHAR) has disclosed a new risk, in the Manufacturing category. Pharming Group Nv faces significant business risk following the U...

Joenja's Journey: Navigating the Market Risks and Regulatory Challenges Post-Approval for Pharming Group Nv

Pharming Group Nv (PHAR) has released an update. Pharming Group N.V., a global biopharmaceutical company, has filed its 2023 Annual Report and Form...

Pharming Group Files Annual Report, Sets AGM Date

Leiden, The Netherlands, April 3, 2024: Pharming Group N.V. ( Pharming ) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will participate in the following investor...

Pharming Group to participate in April investor conferences

Silverberg Bernstein Capital Management LLC bought a new stake in Pharming Group (NASDAQ:PHAR  Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities...

Silverberg Bernstein Capital Management LLC Makes New Investment in Pharming Group (NASDAQ:PHAR)

Pharming Group (NASDAQ:PHAR  Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.05 by...

Pharming Group (NASDAQ:PHAR) Releases Quarterly  Earnings Results, Misses Expectations By $0.08 EPS

Q4 2023 Pharming Group NV Earnings Call Transcript

Pharming Group (NASDAQ:PHAR  Get Free Report)s share price gapped up prior to trading on Friday . The stock had previously closed at $10.92, but opened at $11.36. Pharming Group shares...

Pharming Group (NASDAQ:PHAR) Shares Gap Up to $10.92

Companies Reporting Before The Bell
 Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
read more...

Earnings Scheduled For March 14, 2024

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

Watchers	856
52-Wk Low	$8.71
52-Wk High	$16.71

Volume	5,404.00
52-Wk High	$16.71
52-Wk Low	$8.71

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.00	--	--	N/A
Q1'24	$0.01	-$0.19	-2814.29%	MISSED
Q4'23	$0.00	-$0.04	-988.89%	MISSED
Q3'23	-$0.13	$0.01	103.85%	BEAT
Q2'23	-$0.10	--	--	N/A

PHAR Pharming Group

About

Feed

News

Earnings

Fundamentals